{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:25:18Z","timestamp":1781191518920,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":183,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.rmcr.2023.101890","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T17:11:04Z","timestamp":1689527464000},"page":"101890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5512-5027","authenticated-orcid":false,"given":"Toru","family":"Hamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Katsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Aibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Nozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Moritaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rmcr.2023.101890_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.08-2586","article-title":"Allergic bronchopulmonary aspergillosis","volume":"135","author":"Agarwal","year":"2009","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.rmcr.2023.101890_bib2","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"Stevens","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmcr.2023.101890_bib3","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1183\/09031936.00139513","article-title":"Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis","volume":"43","author":"Moss","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmcr.2023.101890_bib4","article-title":"Successful treatment with mepolizumab in a case of allergic bronchopulmonary aspergillosis complicated with nontuberculous mycobacterial infection","volume":"28","author":"Tsubouchi","year":"2019","journal-title":"Respir. Med. Case Rep."},{"key":"10.1016\/j.rmcr.2023.101890_bib5","article-title":"Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of chronic eosinophilic pneumonia and allergic bronchopulmonary aspergillosis - case series, Almoosa specialist hospital","volume":"34","author":"Eldaabossi","year":"2021","journal-title":"Respir. Med. Case Rep."},{"issue":"1","key":"10.1016\/j.rmcr.2023.101890_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.696","article-title":"Mepolizumab use in cystic fibrosis-associated allergic bronchopulmonary aspergillosis","volume":"9","author":"Boyle","year":"2020","journal-title":"Respirol. Case Rep."},{"key":"10.1016\/j.rmcr.2023.101890_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620961648","article-title":"Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review","volume":"14","author":"Eraso","year":"2020","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"3","key":"10.1016\/j.rmcr.2023.101890_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.alit.2018.12.008","article-title":"Case series of allergic bronchopulmonary aspergillosis treated successfully and safely with long-term mepolizumab","volume":"68","author":"Soeda","year":"2019","journal-title":"Allergol. Int."},{"key":"10.1016\/j.rmcr.2023.101890_bib9","first-page":"59","article-title":"Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: case report and review of the literature","volume":"26","author":"Hirota","year":"2019","journal-title":"Respir. Med. Case Rep."},{"issue":"1","key":"10.1016\/j.rmcr.2023.101890_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12890-018-0617-5","article-title":"A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab","volume":"18","author":"Terashima","year":"2018","journal-title":"BMC Pulm. Med."},{"issue":"4","key":"10.1016\/j.rmcr.2023.101890_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.alit.2018.03.004","article-title":"Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab","volume":"67","author":"Oda","year":"2018","journal-title":"Allergol. Int."},{"issue":"4","key":"10.1016\/j.rmcr.2023.101890_bib12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jaip.2017.01.013","article-title":"Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis","volume":"5","author":"Altman","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"7","key":"10.1016\/j.rmcr.2023.101890_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.465","article-title":"Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab","volume":"7","author":"Matsumoto","year":"2019","journal-title":"Respirol. Case Rep."},{"issue":"7","key":"10.1016\/j.rmcr.2023.101890_bib14","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.jaip.2020.03.023","article-title":"Mepolizumab for allergic bronchopulmonary aspergillosis: report of 20 cases from the Belgian Severe Asthma Registry and review of the literature","volume":"8","author":"Schleich","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"8","key":"10.1016\/j.rmcr.2023.101890_bib15","article-title":"Mepolizumab as possible treatment for allergic bronchopulmonary aspergillosis: a review of eight cases","volume":"12","author":"Tolebeyan","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.rmcr.2023.101890_bib16","article-title":"Mepolizumab improved airway hyperresponsiveness in a patient with allergic bronchopulmonary aspergillosis","author":"Onitsuka","year":"2021","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.rmcr.2023.101890_bib17","article-title":"Successful treatment with mepolizumab for allergic bronchopulmonary mycosis complicated with bilateral septic arthritis of the knee joints caused by methicillin-resistant Staphylococcus aureus","volume":"31","author":"Yanagihara","year":"2020","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.rmcr.2023.101890_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejim.2021.12.026","article-title":"One-year mepolizumab for Allergic bronchopulmonary aspergillosis: focus on steroid sparing effect and markers of response","volume":"99","author":"Caminati","year":"2022","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2023.101890_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13223-019-0397-3","article-title":"Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series","volume":"16","author":"Zhang","year":"2020","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"6","key":"10.1016\/j.rmcr.2023.101890_bib20","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jaip.2021.02.048","article-title":"Real-world effectiveness of anti-IL-5\/5R therapy in severe atopic eosinophilic asthma with fungal sensitization","volume":"9","author":"Dhariwal","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"4","key":"10.1016\/j.rmcr.2023.101890_bib21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jaci.2020.08.029","article-title":"New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation","volume":"147","author":"Asano","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.rmcr.2023.101890_bib22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.rmcr.2023.101890_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2016.11.019","article-title":"Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature","volume":"122","author":"Li","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmcr.2023.101890_bib24","article-title":"Omalizumab in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis","author":"Jin","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"4","key":"10.1016\/j.rmcr.2023.101890_bib25","doi-asserted-by":"crossref","first-page":"omaa029","DOI":"10.1093\/omcr\/omaa029","article-title":"Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis","volume":"2021","author":"Ali","year":"2021","journal-title":"Oxf. Med. Case Rep."},{"issue":"17","key":"10.1016\/j.rmcr.2023.101890_bib26","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.2169\/internalmedicine.6679-20","article-title":"Successful treatment of mepolizumab- and prednisolone-resistant allergic bronchopulmonary aspergillosis with dupilumab","volume":"60","author":"Mikura","year":"2021","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.rmcr.2023.101890_bib27","first-page":"649","article-title":"Biologics for the treatment of allergic conditions: eosinophil disorders","volume":"40","author":"Olivieri","year":"2020","journal-title":"Immunol. Allergy Clin."},{"issue":"Suppl_2","key":"10.1016\/j.rmcr.2023.101890_bib28","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1093\/mmy\/myy063","article-title":"Challenging cases in fungal asthma","volume":"57","author":"Agarwal","year":"2019","journal-title":"Med. Mycol."},{"issue":"5","key":"10.1016\/j.rmcr.2023.101890_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2018.09.033","article-title":"Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma","volume":"143","author":"Khatri","year":"2019","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007123000850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007123000850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:06:33Z","timestamp":1761959193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007123000850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":29,"alternative-id":["S2213007123000850"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2023.101890","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2023.101890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101890"}}